Merck Reports Results from the P-III (KEYNOTE-B21) Study of Keytruda Plus Chemotherapy for Endometrial Cancer
Shots: The P-III (
Shots: The P-III (
Shots: The P-III (DREAMS-2) trial assesses the safety & efficacy of mazdutide...
Shots: The P-I/II (
Shots: Modalis Therapeutics presented supportive preclinical data of MDL-101...
Shots: Following the IND clearance, company plans to initiate P-Ia trial evaluatin...
Incisive News in 3 Shots.